Ibnsina Pharma
- 11.30 EGP
- -0.10
- -0.88%
Ibnsina Pharma Stock Overview
View Company ProfileStock Summary
| Last Price (EGP) | 11.30 |
| Prev. Close | 11.400 |
| Day Range | 11.08 - 11.51 |
| 52WK range | |
| Turnover (M EGP) | 42.76 |
| Volume (M) | 3.81 |
| Number of Trades | 2,026 |
| Market Cap (M EGP) | 11,491.20 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 11.36 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
EBRD grants EGP 1.3bn loan to Ibnsina Pharma for new...
Cairo - Mubasher: The European Bank for Reconstruction and Development (EBRD) is extending an EGP 1.30 billion (EUR 23.10 million) loan to Ibnsina Pharma...
Ibnsina Pharma pens import, distribution deal with...
Cairo – Mubasher: Ibnsina Pharma, Egypt’s fastest-growing and second-largest pharmaceutical distributor, has signed an import and distribution...
Ibnsina Pharma's OGM approves EGP 0.10/shr dividends
Cairo – Mubasher: The ordinary general meeting (OGM) of Ibnsina Pharma has approved a cash dividend distribution of EGP 0.10 per share...
Ibnsina Pharma's EGM approves capital raise through...
Cairo – Mubasher: The extraordinary general meeting (EGM) of Ibnsina Pharma has approved an increase in the company's issued...
Ibnsina Pharma's profit up 21% in nine months
Cairo – Mubasher: Ibnsina Pharma achieved consolidated net profits of EGP 241.94 million in the first nine months of 2021, up by 20.6% year-on-year...
